The Glycogen Storage Disease Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of glycogen storage diseases (GSD), advancements in diagnostic technologies, and the rising demand for effective treatment options. The market is...